Novavax, Inc.
Status: Publicly traded
Direct answer
Novavax, Inc. is publicly traded on NASDAQ under the ticker NVAX.
Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal...
Can you invest in Novavax, Inc.?
Yes. Novavax, Inc. trades publicly on NASDAQ as NVAX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Novavax, Inc.
Detailed equity research is provided by MarketSnap.